Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Trump, FDA and Hims
Hims & Hers Shares Jump as Trump FDA Pick Seen as Major Ally
Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a major beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration.
Hims & Hers jumps after Trump nominates Dr. Marty Makary for FDA
Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns
Who is Dr. Marty Makary, Trump’s pick to head the FDA?
The nominee, a surgeon at Johns Hopkins, has criticized the use of pesticides on food and the industry turning against “natural fat.”
Nano Nuclear Energy, Cassava Sciences, and Hims & Hers
Three Stocks: Nano Nuclear Energy, Cassava Sciences, and Hims & Hers
Cassava Sciences ( SAVA) stock dropped 87% on Monday to close the day’s trading at $4.29 a shares. Cassava is a biotechnology company primarily focused on the research and development of drugs for neurodegenerative diseases, such as Alzheimer's disease.
NANO Nuclear Energy Stock Sinks on Private Placement Pricing
Shares of NANO Nuclear Energy tumbled after the company launched a private placement that valued its stock at $24 a share, well below last week's closing price. The stock was down 19% at $27.13 in early trading.
NANO Nuclear Energy Announces $60 Million Private Placement with Three Accredited Institutional Investors
Cash position expected to be at over $120 Million in just under 7 months as a public companyFinancing provides cash runway to expedite
3d
on MSN
The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.
The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...
3d
on MSN
Hims & Hers New Growth Category Is a Huge Surprise
Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...
bovnews
16h
Hims & Hers Health Inc (HIMS) Stock: More Strategic Than Meets the Eye
On Friday, Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $25.33 which represents a slight increase of $1.18 or 4.89% from the prior close of $24.15. The stock opened at ...
9h
Hunterbrook goes long Hims & Hers after short position in June
After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.
5d
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead
Hims & Hers' financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and ...
AOL
12d
What's Going On With Hims & Hers Health Stock On Wednesday?
Health and wellness platform
Hims
& Hers Health, Inc. (NYSE:
HIMS
), which has gained traction for its obesity-related ...
5d
on MSN
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
11d
Amazon's push into telehealth knocks shares of Hims & Hers
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...
Wall Street Journal
11d
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
Shares of
Hims
& Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...
9h
Hims & Hers surges: Analysts say it's well-positioned under Trump
Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Presidential transition of Donald Trump
Marty Makary
Food and Drug Administration
Amazon
Hers
Feedback